Study on the biovailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry

Biomedical Chromatography

Volumn 19, Issue 5, 2005, Pages 375-378

  Cui, Shengmiao ^a   Zhao, Chunshun ^b   Tang, Xing ^a   Chen, Dawei ^a   He, Zonggui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Biovailability; HPLC MS; Pueraria lobata isoflavone; Puerarin; Self microemulsifying drug delivery systems; Yufenningxin tablets

Indexed keywords

BIOCHEMISTRY; BODY FLUIDS; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; FLAVONOIDS; MASS SPECTROMETRY; TARGETED DRUG DELIVERY;

BIOVAILABILITY; HPLC-MS; ISOFLAVONES; LIQUID CHROMATOGRAPHY - MASS SPECTROMETRIES; PUERARIA LOBATA; PUERARIA LOBATA ISOFLAVONE; PUERARIN; RELATIVE STANDARDS DEVIATIONS; SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEMS; YUFENNINGXIN TABLET;

LIQUID CHROMATOGRAPHY;

4 HYDROXYBENZALDEHYDE; ISOFLAVONE; PUERARIN; ISOFLAVONE DERIVATIVE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MALE; MICROEMULSION; NONHUMAN; PUERARIA; QUANTITATIVE ANALYSIS; RABBIT; SEPARATION TECHNIQUE; TABLET; VALIDATION PROCESS; ANIMAL; BIOAVAILABILITY; CHEMISTRY; EMULSION; MASS SPECTROMETRY; METHODOLOGY; ORAL DRUG ADMINISTRATION; VALIDATION STUDY;

ORYCTOLAGUS CUNICULUS; PUERARIA MONTANA VAR. LOBATA;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, LIQUID; DRUG DELIVERY SYSTEMS; EMULSIONS; ISOFLAVONES; MALE; MASS SPECTROMETRY; PUERARIA; RABBITS;

EID: 22244443039     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.460     Document Type: Article

References (9)

1. Itoh K, Tozuka Y, Oguchi T and Yamamoto K. Improvement of physicochemical properties of N-4472 part I formulation design by using self-microemulsifying system. International Journal of Pharmaceutics 2002; 238: 153-160.
2. Jin X and Zhu X. Pharmacokinetics of puerarin in rats, rabbits, and dogs. Acta Pharmacologica Sinica 1992; 13(3): 284-288.
3. Kim HJ, Yoon KA, Hahn M, Park ES and Chi SC. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Development and Industrial Pharmacy 2000; 26(5): 523-529.
4. Li Y and Yang Y. Clinical treatment by puerarin in patients with senile ischemic cerebrovascular disease. Chinese Pharmaceutical Journal 1997; 32(12): 776-777.
5. Liu Q, Lu Z and Wang L. Restrictive effect of puerarin on myocardial infarct area in dogs and its possible mechanism. Journal of Tongji Medical University 2000; 20(1): 43-45.
6. Ning Y, Ou S, Tang A and Wu J. Effect of puerarin on blood SOD and MDA in patients with angina pectoris. Journal of Hunan Medical University 1997; 22(1): 93-94.
7. Pouton CW. Formulation of self-emulsifying drug delivery systems. Advanced Drug Delivery Reviews 1997; 25: 47-58.
8. Shah NH, Carvajal MT, Patel CI, Infeld MH and Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. International Journal of Pharmaceutics 1994; 106: 15-23.
9. Zhang Z, You X, He Q and Liao G. Determination of puerarin in plasma by HPLC. Chinese Pharmaceutical Journal 1997; 32(2): 104-106.